| Basics |
Medicinova Inc
MediciNova Inc is a biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
|
| IPO Date: |
December 7, 2006 |
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Market Cap: |
$76.51M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.12 | 2.67%
|
| Avg Daily Range (30 D): |
$0.05 | 3.29%
|
| Avg Daily Range (90 D): |
$0.03 | 2.21%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.12M |
| Avg Daily Volume (30 D): |
1.63M |
| Avg Daily Volume (90 D): |
.58M |
| Trade Size |
| Avg Trade Size (Sh.): |
162 |
| Avg Trade Size (Sh.) (30 D): |
241 |
| Avg Trade Size (Sh.) (90 D): |
240 |
| Institutional Trades |
| Total Inst.Trades: |
59 |
| Avg Inst. Trade: |
$1.84M |
| Avg Inst. Trade (30 D): |
$.57M |
| Avg Inst. Trade (90 D): |
$.55M |
| Avg Inst. Trade Volume: |
.29M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.19M |
| Avg Closing Trade (30 D): |
$M |
| Avg Closing Trade (90 D): |
$M |
| Avg Closing Volume: |
538.88K |
|
|
| Financials |
| |
TTM |
Q3 2025 |
Q2 2025 |
|
Basic EPS
|
|
$-.06
|
$-.07
|
|
Diluted EPS
|
|
$-.06
|
$-.07
|
|
Revenue
|
$
|
$ .12M
|
$ .13M
|
|
Gross Profit
|
$
|
$
|
$
|
|
Net Income / Loss
|
$
|
$ -3.05M
|
$ -3.28M
|
|
Operating Income / Loss
|
$
|
$ -3.38M
|
$ -3.61M
|
|
Cost of Revenue
|
$
|
$
|
$
|
|
Net Cash Flow
|
$
|
$ 6.09M
|
$ -2.31M
|
|
PE Ratio
|
|
|
|
| Splits |
|
Oct 31, 2006:
1:10
|
|
|
|
